<?xml version="1.0"?>
<Document>

	<Sentence>
		<value>Von Willebrand disease is the most common hereditary bleeding disorder.</value>
		<pattern_crowdsource> [[Von Willebrand disease|C0042974]] is the most common [[hereditary bleeding disorder|C0019247]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Von Willebrand disease</surface-form>
				<RDF-ID>C0042974</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>most</surface-form>
				<RDF-ID>C0205393</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>common</surface-form>
				<RDF-ID>C0205214</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>bleeding</surface-form>
				<RDF-ID>C0019080</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hereditary bleeding disorder</surface-form>
				<RDF-ID>C0019247</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0042974 ISA C0019247</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>- Abnormal menstrual bleeding  - Bleeding of the gums  - Bruising  - Nosebleeds  - Skin rash   Note: Most women with heavy or prolonged menstrual bleeding do not have Von Willebrand disease.</value>
		<pattern_crowdsource> - Abnormal menstrual bleeding  - Bleeding of the gums  - Bruising  - Nosebleeds  - Skin rash   Note: Most [[women|C0043210]] with heavy or prolonged menstrual bleeding do not have [[Von Willebrand disease|C0042974]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Abnormal menstrual</surface-form>
				<RDF-ID>C0025345</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>bleeding</surface-form>
				<RDF-ID>C0019080</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>gums</surface-form>
				<RDF-ID>C0017562</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Bruising</surface-form>
				<RDF-ID>C0009938</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Nosebleeds</surface-form>
				<RDF-ID>C0014591</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Skin rash</surface-form>
				<RDF-ID>C0015230</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Note</surface-form>
				<RDF-ID>C1317574</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>women</surface-form>
				<RDF-ID>C0043210</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>prolonged menstrual</surface-form>
				<RDF-ID>C0425945</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>bleeding</surface-form>
				<RDF-ID>C0019080</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>not</surface-form>
				<RDF-ID>C1518422</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Von Willebrand disease</surface-form>
				<RDF-ID>C0042974</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0042974 NEG_PROCESS_OF C0043210</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Treatment may include DDAVP (desamino-8-arginine vasopressin), a medicine to raise von Willebrand factor level and reduce the chances for bleeding.</value>
		<pattern_crowdsource> Treatment may include [[DDAVP|C0701195]] (desamino-8-[[arginine vasopressin|C0003779]]), a [[medicine|C0013227]] to raise [[von Willebrand factor|C0015513]] level and reduce the chances for [[bleeding|C0019080]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Treatment</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>DDAVP</surface-form>
				<RDF-ID>C0701195</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>arginine vasopressin</surface-form>
				<RDF-ID>C0003779</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>medicine</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>von Willebrand factor</surface-form>
				<RDF-ID>C0015513</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>chances</surface-form>
				<RDF-ID>C0237506</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>bleeding</surface-form>
				<RDF-ID>C0019080</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0701195 ISA C0003779</triple>
			<triple>C0013227 STIMULATES C0015513</triple>
			<triple>C0701195 TREATS C0019080</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>If you are going to have surgery, your doctor may give you DDAVP before surgery to see if your von Willebrand factor levels increase.</value>
		<pattern_crowdsource> If you are going to have surgery, your [[doctor|C0031831]] may give you [[DDAVP|C0701195]] before surgery to see if your von Willebrand factor levels increase.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>surgery</surface-form>
				<RDF-ID>C0543467</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>doctor</surface-form>
				<RDF-ID>C0031831</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>DDAVP</surface-form>
				<RDF-ID>C0701195</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>surgery</surface-form>
				<RDF-ID>C0543467</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>von Willebrand factor</surface-form>
				<RDF-ID>C0042971</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>levels</surface-form>
				<RDF-ID>C0441889</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0701195 ADMINISTERED_TO C0031831</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>The drug Alphanate (antihemophilic factor) is approved to decrease bleeding in patients with the disease who must have surgery or any other invasive procedure.</value>
		<pattern_crowdsource> The [[drug|C0013227]] [[Alphanate|C0594139]] (antihemophilic factor) is approved to decrease [[bleeding|C0019080]] in [[patients|C0030705]] with the [[disease|C0012634]] who must have surgery or any other invasive procedure.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>drug</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Alphanate</surface-form>
				<RDF-ID>C0594139</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>antihemophilic factor</surface-form>
				<RDF-ID>C0200400</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>bleeding</surface-form>
				<RDF-ID>C0019080</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>patients</surface-form>
				<RDF-ID>C0030705</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>disease</surface-form>
				<RDF-ID>C0012634</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>surgery</surface-form>
				<RDF-ID>C0543467</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>invasive procedure</surface-form>
				<RDF-ID>C0348025</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0594139 ISA C0013227</triple>
			<triple>C0594139 INHIBITS C0019080</triple>
			<triple>C0019080 PROCESS_OF C0030705</triple>
			<triple>C0012634 PROCESS_OF C0030705</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Blood plasma or certain factor VIII preparations may also be used to decrease bleeding.</value>
		<pattern_crowdsource> Blood plasma or certain [[factor VIII preparations|C0301494]] may also be used to decrease [[bleeding|C0019080]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Blood plasma</surface-form>
				<RDF-ID>C0032105</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>certain</surface-form>
				<RDF-ID>C0205423</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>factor VIII preparations</surface-form>
				<RDF-ID>C0301494</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>bleeding</surface-form>
				<RDF-ID>C0019080</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0301494 INHIBITS C0019080</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Women who have this condition usually do not have excessive bleeding during childbirth.</value>
		<pattern_crowdsource> [[Women|C0043210]] who have this condition usually do not have excessive [[bleeding|C0019080]] during childbirth.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Women</surface-form>
				<RDF-ID>C0043210</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>condition</surface-form>
				<RDF-ID>C0348080</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>not</surface-form>
				<RDF-ID>C1518422</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>excessive</surface-form>
				<RDF-ID>C0442802</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>bleeding</surface-form>
				<RDF-ID>C0019080</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>childbirth</surface-form>
				<RDF-ID>C1148523</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0019080 NEG_PROCESS_OF C0043210</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) can make this condition worse.</value>
		<pattern_crowdsource> [[Aspirin|C0004057]] and other [[nonsteroidal anti-inflammatory drugs|C0003211]] (NSAIDs) can make this condition worse.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Aspirin</surface-form>
				<RDF-ID>C0004057</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>nonsteroidal anti-inflammatory drugs</surface-form>
				<RDF-ID>C0003211</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>condition</surface-form>
				<RDF-ID>C0348080</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>worse</surface-form>
				<RDF-ID>C1279889</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0004057 ISA C0003211</triple>
			<triple>C0003211 ISA C0004057</triple>
		</triples>
	</Sentence>

</Document>

